| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | 147,3 k € | +16.5% | 126,4 k € | +40.2% | 90,2 k € | -18.8% | 111,1 k € | -32.8% | 165,3 k € | +6.4% | 155,4 k € | -0.6% | 156,3 k € | -40.1% | 260,9 k € | +254.3% | 73,6 k € | -46.2% | 136,9 k € | -27.9% | 189,8 k € | — | — | — | 226,5 k € | |||||||||
| Gross margin | -38,9 k € | +56.7% | -89,8 k € | -296.8% | -22,6 k € | -113.3% | 170,2 k € | +237.8% | 50,4 k € | +70.4% | 29,6 k € | -11.6% | 33,5 k € | +35.3% | 24,7 k € | -58.1% | 59,0 k € | +307.9% | 14,5 k € | -82.5% | 82,8 k € | -2.2% | 84,7 k € | +730.6% | 10,2 k € | -61.8% | 26,7 k € | -77.0% | 115,9 k € | +96.2% | 59,1 k € | -45.3% | 108,0 k € | -34.7% | 165,4 k € | +77.7% | 93,1 k € | |
| EBITDA | -143,5 k € | +32.6% | -212,8 k € | -69.2% | -125,8 k € | -223.9% | 101,6 k € | +737.4% | -15,9 k € | +50.3% | -32,0 k € | +8.6% | -35,1 k € | +4.0% | -36,5 k € | -1301.3% | -2,6 k € | +94.6% | -48,1 k € | -271.4% | 28,1 k € | +33.4% | 21,1 k € | +146.6% | -45,2 k € | -110.8% | -21,4 k € | -128.5% | 75,1 k € | +374.0% | 15,8 k € | -70.0% | 52,8 k € | -61.3% | 136,2 k € | +107.3% | 65,7 k € | |
| Operating profit | -157,5 k € | +29.0% | -221,8 k € | -63.1% | -135,9 k € | -261.9% | 84,0 k € | +368.0% | -31,3 k € | +33.9% | -47,4 k € | +3.4% | -49,0 k € | +3.7% | -50,9 k € | -227.4% | -15,5 k € | +74.5% | -61,1 k € | -498.9% | 15,3 k € | +70.1% | 9,0 k € | +114.0% | -64,2 k € | -23.3% | -52,1 k € | -220.4% | 43,2 k € | +302.4% | -21,3 k € | -174.8% | 28,5 k € | -73.1% | 106,3 k € | +89.9% | 56,0 k € | |
| Profit/loss | -157,8 k € | +29.2% | -222,8 k € | -63.6% | -136,2 k € | -263.4% | 83,3 k € | +359.1% | -32,2 k € | +32.4% | -47,6 k € | +8.5% | -52,0 k € | -0.7% | -51,7 k € | -216.3% | -16,3 k € | +73.5% | -61,6 k € | -561.3% | 13,3 k € | +90.6% | 7,0 k € | +110.5% | -66,4 k € | -492.8% | -11,2 k € | -339.3% | 4,7 k € | +466.1% | 827,0 € | -97.6% | 33,8 k € | -42.0% | 58,4 k € | +92.2% | 30,4 k € | |
| Equity | -678,7 k € | -30.3% | -520,8 k € | -74.8% | -298,0 k € | -2795.4% | 11,1 k € | +115.3% | -72,3 k € | -80.2% | -40,1 k € | -634.3% | 7,5 k € | -87.4% | 59,5 k € | -46.5% | 111,2 k € | -12.8% | 127,5 k € | -32.6% | 189,1 k € | +7.6% | 175,7 k € | +4.1% | 168,7 k € | -28.2% | 235,1 k € | -7.8% | 255,1 k € | +1.0% | 252,6 k € | -0.7% | 254,3 k € | +14.0% | 223,0 k € | +33.4% | 167,2 k € | |
| Total assets | 231,7 k € | -9.6% | 256,4 k € | +18.4% | 216,6 k € | -13.0% | 249,0 k € | -4.6% | 261,0 k € | -12.3% | 297,4 k € | -17.4% | 359,9 k € | -29.5% | 510,7 k € | -12.1% | 581,1 k € | +50.4% | 386,3 k € | -15.3% | 456,1 k € | +27.5% | 357,6 k € | +3.9% | 344,3 k € | -23.7% | 451,3 k € | -16.5% | 540,2 k € | +10.4% | 489,2 k € | +0.0% | 489,2 k € | +6.2% | 460,5 k € | +8.7% | 423,4 k € | |
| Cash | 1,5 k € | +2367.1% | 58,8 € | -98.5% | 4,0 k € | -63.9% | 11,1 k € | -67.1% | 33,9 k € | -38.7% | 55,3 k € | -41.6% | 94,6 k € | -38.1% | 152,7 k € | -16.0% | 181,8 k € | +1030.1% | 16,1 k € | -81.8% | 88,6 k € | +69.4% | 52,3 k € | +15.7% | 45,2 k € | -74.5% | 177,1 k € | +3.7% | 170,8 k € | -4.1% | 178,0 k € | -14.2% | 207,4 k € | +12.5% | 184,3 k € | +9.4% | 168,5 k € | |
| Debts | 910,4 k € | +17.1% | 777,2 k € | +51.0% | 514,6 k € | +116.2% | 238,0 k € | -28.6% | 333,2 k € | -1.3% | 337,5 k € | -4.2% | 352,4 k € | -21.9% | 451,1 k € | -4.0% | 469,9 k € | +81.6% | 258,8 k € | -3.1% | 267,0 k € | +46.8% | 181,9 k € | +3.6% | 175,5 k € | -18.8% | 216,1 k € | -24.2% | 285,0 k € | +20.4% | 236,7 k € | +0.9% | 234,6 k € | -1.2% | 237,5 k € | -6.8% | 254,9 k € | |
| Staff | — | — | — | — | — | — | 1 | 1 | 1 | 1 | 1 | 1,3 | 1 | 1 | 0,9 | 1,3 | 1,3 | 0,9 | 0,7 | |||||||||||||||||||
Public limited company · Charleroi · incorporated on 03/12/1991
Public limited company loss-making in the latest fiscal year. Cash position rising (+2367.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MEDESTIME is a Public limited company incorporated in 1991. Its main activity is: Manufacture of medical and dental instruments and supplies. Its registered office is in Charleroi.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette